A detailed history of Kpp Advisory Services LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kpp Advisory Services LLC holds 6,885 shares of BMY stock, worth $397,126. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,885
Previous 7,365 6.52%
Holding current value
$397,126
Previous $306 Million 16.47%
% of portfolio
0.09%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$39.66 - $51.75 $19,036 - $24,840
-480 Reduced 6.52%
6,885 $356 Million
Q2 2024

Aug 27, 2024

SELL
$40.25 - $52.99 $22,902 - $30,151
-569 Reduced 7.17%
7,365 $306 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $25,285 - $28,668
-527 Reduced 6.23%
7,934 $430 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $75,968 - $90,650
-1,567 Reduced 15.63%
8,461 $434 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $580,520 - $649,112
10,028 New
10,028 $582 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kpp Advisory Services LLC Portfolio

Follow Kpp Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kpp Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kpp Advisory Services LLC with notifications on news.